Rosalinde Masereeuw

Prof. Rosalinde Masereeuw

Utrecht Institute for Pharmaceutical Sciences
orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2019 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
FSFrans Schutgens
Frans Schutgens
MRMaarten B Rookmaaker
Maarten B Rookmaaker
TMThanasis Margaritis
Thanasis Margaritis
ARAnne Rios
Anne Rios
CACarola Ammerlaan
Carola Ammerlaan
Hans CleversHans Clevers
Hans Clevers

1 April 2008 in Trends in Pharmacological Sciences
Verified
Journal Article
Closed access
FRFrans G.M. Russel
Frans G.M. Russel
JKJ Koenderink
J Koenderink
RMRosalinde Masereeuw
Rosalinde Masereeuw

1 February 2016 in Trends in Biotechnology
Verified
Journal Article
Closed access
MWMartijn J. Wilmer
Martijn J. Wilmer
CNChee Ping Ng
Chee Ping Ng
HLHenriëtte L. Lanz
Henriëtte L. Lanz
PVPaul Vulto
Paul Vulto
LSLaura Suter-Dick
Laura Suter-Dick
RMRosalinde Masereeuw
Rosalinde Masereeuw

16 June 2010 in Journal of Nuclear Medicine
Verified
Journal Article
Open access
PDF file
EVErik Vegt
Erik Vegt
MJMarion de Jong
Marion de Jong
JWJack F.M. Wetzels
Jack F.M. Wetzels
RMRosalinde Masereeuw
Rosalinde Masereeuw
MMMarleen Melis
Marleen Melis
OBOtto C. Boerman
Otto C. Boerman
Peptide-receptor radionuclide therapy (PRRT) with radiolabeled somatostatin analogs such as octreotide is an effective therapy against neuroendocrine tumors. Other radiolabeled peptides and antibody fragments are under investigation. Most of these compounds are cleared through the kidneys and reabsorbed and partially retained in the proximal tubules, causing dose-limiting nephrotoxicity. An overview of renal handling of radiolabeled peptides and resulting nephrotoxicity is presented, and strategies to reduce nephrotoxicity are discussed. Modification of size, charge, or structure of radiolabeled peptides can alter glomerular filtration and tubular reabsorption. Coinfusion of competitive inhibitors of reabsorption also interferes with the interaction of peptides with renal endocytic receptors; coinfusion of basic amino acids is currently used for kidney protection in clinical PRRT. Furthermore, nephrotoxicity may be reduced by dose fractionation, use of radioprotectors, or use of mitigating agents. Decreasing the risk of nephrotoxicity allows for administration of higher radiation doses, increasing the effectiveness of PRRT.

1 January 2008 in Kidney International
Verified
Journal Article
Closed access
MHM. Huls
M. Huls
CBC.D.A. Brown
C.D.A. Brown
AWA.S. Windass
A.S. Windass
RSR. Sayer
R. Sayer
JHJ.J.M.W. van Den Heuvel
J.J.M.W. van Den Heuvel
RMRosalinde Masereeuw
Rosalinde Masereeuw

9 March 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
JGJiaxing Gong
Jiaxing Gong
CSCarl C. L. Schuurmans
Carl C. L. Schuurmans
AGAnne Metje van Genderen
Anne Metje van Genderen
XCXia Cao
Xia Cao
WLWanlu Li
Wanlu Li
Yu Shrike ZhangYu Shrike Zhang
Yu Shrike Zhang
Three-dimensional (3D) hydrogel printing enables production of volumetric architectures containing desired structures using programmed automation processes. Our study reports a unique method of resolution enhancement purely relying on post-printing treatment of hydrogel constructs. By immersing a 3D-printed patterned hydrogel consisting of a hydrophilic polyionic polymer network in a solution of polyions of the opposite net charge, shrinking can rapidly occur resulting in various degrees of reduced dimensions comparing to the original pattern. This phenomenon, caused by complex coacervation and water expulsion, enables us to reduce linear dimensions of printed constructs while maintaining cytocompatible conditions in a cell type-dependent manner. We anticipate our shrinking printing technology to find widespread applications in promoting the current 3D printing capacities for generating higher-resolution hydrogel-based structures without necessarily having to involve complex hardware upgrades or other printing parameter alterations.